Results 31 to 40 of about 214,701 (178)

The Effect of Paraprotein on Platelet Aggregation [PDF]

, 2014
Background Some patients with paraproteinemia have platelet aggregation disorders and the aim of this study was to examine disturbance of platelet aggregation in healthy blood donors by isolated paraprotein in vitro.
Amzel, Apitz, Born, Decourt, Di Minno, Dighiero, Edelman, Edelman, Freedman, Garver, Jefferis, Jefferis, Kawai, Kerr, Lefranc, Libman, Mejbaum-Katzenellenbogen, Porter, Recht, Riva, Robert, Sagan, Shinagawa, Spicka, Spicka, Stanworth, Tricot, Virella, Werner   +28 more
core   +1 more source

Platelet aggregation and quality control of platelet concentrates produced in the Amazon Blood Bank

Revista Brasileira de Hematologia e Hemoterapia, 2011
BACKGROUND: The study of platelet aggregation is essential to assess in vitro platelet function by different platelet activation pathways. OBJECTIVE: To assess aggregation and biochemical parameters of random platelet concentrates produced at the ...
Maria José Dantas Coêlho, Taysa de Castro Monteiro, Felicien Gonçalves Vasquez, Kátia Luz Torres Silva, Kleber Sandro Brasil dos Santos, Viviana Maria Araújo de Oliveira, Francimary de Oliveira Cavalcante   +6 more
doaj   +1 more source

Antiprothrombin antibodies induce platelet activation : a possible explanation for anti‐FXa therapy failure in patients with antiphospholipid syndrome? [PDF]

, 2021
Background Arterial and venous thrombosis are both common in antiphospholipid syndrome (APS). Recent studies have shown that anti-factor Xa (FXa) therapy in APS patients leads to a greater number of patients with arterial thrombosis than with warfarin ...
Chayoua, Walid, Devreese, Katrien, Garcia‐Quintanilla, Lourdes, Groot, Philip G., Kardeby, Caroline, Laat, Bas, Meijers, Joost C.M., Nicolson, Phillip L.R., Watson, Stephen P.   +8 more
core   +4 more sources

Digoxin and platelet activation in patients with atrial fibrillation: In vivo and in vitro study [PDF]

, 2018
Background-Digoxin use was shown to be associated with an increased risk of cardiovascular events in atrial fibrillation (AF). We hypothesized that digoxin may affect cardiovascular risk by increasing platelet activation.
Bartimoccia, Simona, Cammisotto, Vittoria, Carnevale, Roberto, Nocella, Cristina, Novo, Marta, Pastori, Daniele, Piconese, Silvia, Pignatelli, Pasquale, Santulli, Maria, Vasaturo, Fortunata, Violi, Francesco   +10 more
core   +1 more source

Thrombopoietin and platelet aggregation in patients with stable coronary artery disease

Platelets, 2017
Thrombopoietin (TPO) may facilitate platelet activation and aggregation. However, data on the impact of TPO on platelet aggregation in patients with stable coronary artery disease (CAD) are scarce.
Sanne Bøjet Larsen, Erik Lerkevang Grove, Søs Neergaard-Petersen, Morten Würtz, Anne-Mette Hvas, Steen Dalby Kristensen   +5 more
doaj   +1 more source

Platelet aggregation in healthy women during normal pregnancy - a longitudinal study

Platelets, 2019
Increased platelet activation is involved in obstetric complications such as preeclampsia and intrauterine growth retardation. It is of interest to study platelet aggregation during pregnancy, since increased aggregation theoretically could be a ...
Lennart Rune Fredrik Blomqvist, Annika Margareta Strandell, Fariba Baghaei, Margareta Sofia Elisabet Hellgren   +3 more
doaj   +1 more source

Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion [PDF]

, 2002
BACKGROUND: GPIIb/IIIa inhibitors abciximab and eptifibatide have been shown to inhibit platelet aggregation in ischemic heart disease. Our aim was to test the efficacy of abiciximab (Reo Pro) or eptifibatide (Integrilin) alone or in combination with ...
Bertuglia, Silva, Giusti, Andrea
core   +2 more sources

Augmentation by resveratrol of the inhibitory effect of ethanol on platelet aggregation

Platelets, 2023
Ethanol and resveratrol have been shown to inhibit platelet aggregation. The aim of this study was to determine whether resveratrol has an additional effect on ethanol-induced inhibition of platelet aggregation.
Kazumi Ekawa, Mikio Marumo, Ichiro Wakabayashi   +2 more
doaj   +1 more source

Targeted deep sequencing of the PEAR1 locus for platelet aggregation in European and African American families

Platelets, 2019
Coronary artery disease (CAD) remains a major cause of mortality and morbidity worldwide. The aggregation of activated platelets on a ruptured atherosclerotic plaque is a critical step in most acute cardiovascular events like myocardial infarction ...
Ali R Keramati, Lisa R Yanek, Kruthika Iyer, Margaret A Taub, Ingo Ruczinski, Diane M Becker, Lewis C Becker, Nauder Faraday, Rasika A Mathias   +8 more
doaj   +1 more source

Human platelet activation by Escherichia coli: roles for FcγRIIA and integrin αIIbβ3 [PDF]

, 2016
Gram-negative Escherichia coli cause diseases such as sepsis and hemolytic uremic syndrome in which thrombotic disorders can be found. Direct platelet–bacterium interactions might contribute to some of these conditions; however, mechanisms of human ...
Arman, Mònica, Cox, Dermot, Henderson, Ian R., Kerrigan, Steven W., Watson, Callum N., Watson, Steve P.   +5 more
core   +3 more sources